Show simple item record

dc.contributor.authorRecasens, Ariadna
dc.contributor.authorDehay, Benjamin
dc.contributor.authorBové, Jordi
dc.contributor.authorCarballo-Carbajal, Iria
dc.contributor.authorDovero, Sandra
dc.contributor.authorPérez-Villalba, Ana
dc.contributor.authorFernagut, Pierre-Olivier
dc.contributor.authorBlesa, Javier
dc.contributor.authorParent, Annabelle
dc.contributor.authorPerier, Celine
dc.contributor.authorFariñas, Isabel
dc.contributor.authorObeso, José
dc.contributor.authorBezard, Erwan
dc.contributor.authorVila, Miquel
dc.date.accessioned2025-01-18T13:13:44Z
dc.date.available2025-01-18T13:13:44Z
dc.date.issued2014
dc.identifier.citationRecasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Dovero, S., Pérez‐Villalba, A., ... & Vila, M. (2014). Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys. Annals of neurology, 75(3), 351-362. https://doi.org/10.1002/ana.24066es
dc.identifier.issn1531-8249
dc.identifier.otherhttps://onlinelibrary.wiley.com/doi/10.1002/ana.24066es
dc.identifier.urihttp://hdl.handle.net/20.500.12020/1522
dc.description.abstractObjective: Mounting evidence suggests that α-synuclein, a major protein component of Lewy bodies (LB), may be responsible for initiating and spreading the pathological process in Parkinson disease (PD). Supporting this concept, intracerebral inoculation of synthetic recombinant α-synuclein fibrils can trigger α-synuclein pathology in mice. However, it remains uncertain whether the pathogenic effects of recombinant synthetic α-synuclein may apply to PD-linked pathological α-synuclein and occur in species closer to humans. Methods: Nigral LB-enriched fractions containing pathological α-synuclein were purified from postmortem PD brains by sucrose gradient fractionation and subsequently inoculated into the substantia nigra or striatum of wild-type mice and macaque monkeys. Control animals received non-LB fractions containing soluble α-synuclein derived from the same nigral PD tissue. Results: In both mice and monkeys, intranigral or intrastriatal inoculations of PD-derived LB extracts resulted in progressive nigrostriatal neurodegeneration starting at striatal dopaminergic terminals. No neurodegeneration was observed in animals receiving non-LB fractions from the same patients. In LB-injected animals, exogenous human α-synuclein was quickly internalized within host neurons and triggered the pathological conversion of endogenous α-synuclein. At the onset of LB-induced degeneration, host pathological α-synuclein diffusely accumulated within nigral neurons and anatomically interconnected regions, both anterogradely and retrogradely. LB-induced pathogenic effects required both human α-synuclein present in LB extracts and host expression of α-synuclein. Interpretation: α-Synuclein species contained in PD-derived LB are pathogenic and have the capacity to initiate a PD-like pathological process, including intracellular and presynaptic accumulations of pathological α-synuclein in different brain areas and slowly progressive axon-initiated dopaminergic nigrostriatal neurodegeneration.es
dc.language.isoenes
dc.publisherWileyes
dc.titleLewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeyses
dc.typearticlees
dc.identifier.doihttps://doi.org/10.1002/ana.24066
dc.issue.number3es
dc.journal.titleAnnals of Neurologyes
dc.page.initial351es
dc.page.final362es
dc.rights.accessRightsclosedAccesses
dc.subject.areaCiencias Biomédicases
dc.subject.keywordParkinson's Diseasees
dc.subject.keywordStriatumes
dc.subject.keywordSynucleines
dc.subject.keywordSubstantia Nigraes
dc.subject.unesco32 Ciencias Médicases
dc.volume.number75es


Files in this item

File/sSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record